These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 19173720)

  • 1. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants.
    Barreto M; Ferreira RC; Lourenço L; Moraes-Fontes MF; Santos E; Alves M; Carvalho C; Martins B; Andreia R; Viana JF; Vasconcelos C; Mota-Vieira L; Ferreira C; Demengeot J; Vicente AM
    BMC Immunol; 2009 Jan; 10():5. PubMed ID: 19173720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives.
    Costa N; Marques O; Godinho SI; Carvalho C; Leal B; Figueiredo AM; Vasconcelos C; Marinho A; Moraes-Fontes MF; Gomes da Costa A; Ponte C; Campanilho-Marques R; Cóias T; Martins AR; Viana JF; Lima M; Martins B; Fesel C
    Clin Exp Immunol; 2017 Sep; 189(3):318-330. PubMed ID: 28542701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
    Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
    Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4
    Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
    Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus.
    Pan X; Yuan X; Zheng Y; Wang W; Shan J; Lin F; Jiang G; Yang YH; Wang D; Xu D; Shen L
    PLoS One; 2012; 7(4):e34662. PubMed ID: 22506043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
    Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
    Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].
    Cai XY; Luo M; Lin XJ; Xu YL; Tang C; Ye JH; Li WN; He ZX; Yu N
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):460-3. PubMed ID: 22490966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.
    Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM
    Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity.
    Zhang L; Bertucci AM; Ramsey-Goldman R; Harsha-Strong ER; Burt RK; Datta SK
    Clin Immunol; 2013 Dec; 149(3):365-78. PubMed ID: 24211843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus.
    Mesquita D; Cruvinel WM; Araujo JA; Salmazi KC; Kallas EG; Andrade LE
    Braz J Med Biol Res; 2014 Aug; 47(8):662-9. PubMed ID: 25098715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
    Hahn BH; Anderson M; Le E; La Cava A
    Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
    Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation of CD4
    Kamal M; Gabr H; Anwar S; Bastawy S; Salah L
    Lupus; 2022 Apr; 31(4):463-471. PubMed ID: 35249399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of regulatory GITR+CD25 low/-CD4+ T cells in systemic lupus erythematosus patients.
    Nocentini G; Alunno A; Petrillo MG; Bistoni O; Bartoloni E; Caterbi S; Ronchetti S; Migliorati G; Riccardi C; Gerli R
    Arthritis Res Ther; 2014 Sep; 16(5):444. PubMed ID: 25256257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
    Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
    Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4(+)CD25(+)CD127(-) and CD4(+)CD25(+)Foxp3(+) Regulatory T Cell Subsets in Mediating Autoimmune Reactivity in Systemic Lupus Erythematosus Patients.
    Żabińska M; Krajewska M; Kościelska-Kasprzak K; Jakuszko K; Bartoszek D; Myszka M; Klinger M
    Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):399-407. PubMed ID: 27156107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Ets-1 and FOXP3 mRNA in CD4(+)CD25 (+) T regulatory cells from patients with systemic lupus erythematosus.
    Xiang N; Li XP; Li XM; Wang GS; Tao JH; Pan HF; Fang X; Ma Q; Yu N
    Clin Exp Med; 2014 Nov; 14(4):375-81. PubMed ID: 24221578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.
    Bonelli M; Savitskaya A; Steiner CW; Rath E; Smolen JS; Scheinecker C
    J Immunol; 2009 Feb; 182(3):1689-95. PubMed ID: 19155519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.